IP Library Granted Patent US 8,792,689
Granted Patent B2
US 8,792,689 · App. 13/217,688 · Granted Jul 29, 2014

Measuring intramuscular fat

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,792,689
App. No.
13/217,688
Granted
Jul 29, 2014
Kind
B2
Abstract

Dual-energy absorptiometry is used to estimate intramuscular adipose tissue metrics and display results, preferably as related to normative data. The process involves deriving x-ray measurements for respective pixel positions related to a two-dimensional projection image of a body slice containing intramuscular adipose tissue as well as subcutaneous adipose tissue, at least some of the measurements being dual-energy x-ray measurements, processing the measurements to derive estimates of metrics related to the intramuscular adipose tissue in the slice, and using the resulting estimates. Processing the measurements includes an algorithm which places boundaries of regions, e.g., a large region and a smaller region. The regions are combined in an equation that is highly correlated with intramuscular adipose tissue measured by quantitative computed tomography in order to estimate intramuscular adipose tissue.

Claims (30)

1. A method comprising:

acquiring x-ray measurements for respective pixel positions related to a two-dimensional projection image of a portion of a subject, wherein at least some of the measurements are dual-energy x-ray measurements;

placing a plurality of regions of the image;

processing, utilizing a computer, to combine the plurality of regions to provide an estimate of intramuscular adipose tissue, wherein the computer processing comprises combining the plurality of regions to provide an estimate of intramuscular adipose tissue by correlating dual-energy x-ray measurements and computed tomography measurements using a linear equation using constants that provide correlation between dual-energy x-ray measured intramuscular adipose tissue and intramuscular adipose tissue measured by computed tomography; and

providing and displaying selected results related to said estimate of intramuscular adipose tissue.

2. The method of claim 1 including placing a first region of the image which extends from a first side of a limb to a second side of the limb, and placing a second region which extends across a muscle area from a first side to a second side between outermost extents of muscle wall.

3. The method of claim 1 including placing a first region of the image which extends from a first side of a limb to a second side of the limb, placing a second region which extends across a muscle area from a first side to a second side between outermost extents of muscle wall but exclusive of a third region which is placed where bone is present and percent fat cannot be directly measured.

4. The method of claim 1 including computer processing at least some of the x-ray measurements for placing at least one region of the image.

5. The method of claim 2 including using an anatomical landmark and a preselected region of interest line for placing the first region of the image.

6. The method of claim 2 including computer processing at least some of the x-ray measurements for placing the second region of the image.

7. The method of claim 6 including identifying a left and a right muscle wall by identifying inflection of adipose tissue values for placing the second region of the image.

8. The method of claim 2 including combining the first region and the second region in a linear equation that is correlated with intramuscular adipose tissue measured by quantitative computed tomography for processing the first and second regions to provide an estimate of intramuscular adipose tissue.

9. The method of claim 8 including calculating intramuscular adipose tissue as: J*muscle region adipose mass−K*(limb adipose mass−muscle region adipose mass)+b, wherein including selecting constants J and K that provide correlation between DXA intramuscular adipose tissue and intramuscular adipose tissue measured by computed tomography, and wherein b is an intercept term.

10. The method of claim 9 including selecting a value for at least one of J, K and b for the subject.

11. The method of claim 10 including selecting a value for at least one of J, K and b based on at least one of age, gender, ethnicity, weight, height, body mass index, waist circumference, and other anthropomorphic variables of the subject.

12. Apparatus comprising:

a data acquisition unit including a scanner that acquires x-ray measurements for respective pixel positions related to a two-dimensional projection image of a portion of a subject's limb, wherein at least some of the measurements are dual-energy x-ray measurements;

a memory in which is placed a plurality of regions of the image;

a computer processor that processes the regions to provide an estimate of intramuscular adipose tissue, wherein the processing unit combines the plurality of regions to provide an estimate of intramuscular adipose tissue by correlating dual-energy x-ray measurements and computed tomography measurements using a linear equation using constants that provide correlation between DXA intramuscular adipose tissue and intramuscular adipose tissue measured by computed tomography; and

a display unit that provides and displays selected results related to intramuscular adipose tissue of the subject.

13. The apparatus of claim 12 wherein a first region and a second region are stored in memory, the first region extending from a first side of the limb to a second side of the limb, and the second region extending across a muscle area from the first side to the second side between outermost extents of muscle wall.

14. The apparatus of claim 12 wherein a first region, a second region, and a third region are stored in memory, the first region extending from a first side of the limb to a second side of the limb, the second region extending across a muscle area from a first side to a second side between outermost extents of muscle wall but exclusive of a third region which is placed where bone is present and percent fat cannot be directly measured.

15. The apparatus of claim 13 wherein the processing unit places the first region of the image by computer-processing at least some of the x-ray measurements.

16. The apparatus of claim 15 wherein the processing unit uses an anatomical landmark and a preselected region of interest line to place the first region of the image.

17. The apparatus of claim 13 wherein the processing unit places the second region of the image by computer-processing at least some of the x-ray measurements.

18. The apparatus of claim 17 wherein the processing unit uses an algorithm to identify a left and a right outermost extent of muscle wall by identifying inflection of adipose tissue values for placing the second region of the image.

19. The apparatus of claim 13 wherein the processing unit combines the first region and the second region using a linear equation which is correlated with intramuscular adipose tissue measured by quantitative computed tomography.

20. The apparatus of claim 19 wherein the processing unit calculates intramuscular adipose tissue as: J*muscle region adipose mass−K*(limb adipose mass−muscle region adipose mass)+b, wherein constants J and K are selected based on correlation between DXA intramuscular adipose tissue and intramuscular adipose tissue measured by computed tomography, and wherein b is an intercept term.

21. The apparatus of claim 20 wherein at least one of J, K and b are selected for the subject.

22. The apparatus of claim 21 wherein at least one of J, K and b are selected based on at least one of age, gender, ethnicity, weight, height, body mass index, waist circumference, and other anthropomorphic variables of the subject.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2011
From: KELLY, THOMAS L.; WILSON, KEVIN E.
To: HOLOGIC INC.
Reel/Frame 026807/0611 →